ArticleDermatology and therapy2026

Secukinumab Plus Upadacitinib for the Treatment of Severe Hidradenitis Suppurativa and Associated Immune-Mediated Comorbidities: A Case Series.

Francisco Javier Melgosa Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.